Cargando…

Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia – Results from a Multicenter Study

BACKGROUND: Systemic inflammation and cachexia are associated with adverse clinical outcomes in elderly patients with cancer. The survival outcomes of elderly patients with cancer cachexia (EPCC) with high inflammation and a high risk of mortality are unknown. This study aimed to investigate the imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Guo-Tian, Yang, Ming, Zhang, Xiao-Wei, Song, Meng-Meng, Hu, Chun-Lei, Ge, Yi-Zhong, Xie, Hai-Lun, Liu, Tong, Tang, Meng, Zhang, Qi, Zhang, Xi, Zhang, Kang-Ping, Li, Xiang-Rui, Li, Qin-Qin, Chen, Yong-Bing, Yu, Kai-Ying, Cong, Ming-Hua, Wang, Kun-Hua, Shi, Han-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558830/
https://www.ncbi.nlm.nih.gov/pubmed/34737602
http://dx.doi.org/10.2147/JIR.S332408
_version_ 1784592644067819520
author Ruan, Guo-Tian
Yang, Ming
Zhang, Xiao-Wei
Song, Meng-Meng
Hu, Chun-Lei
Ge, Yi-Zhong
Xie, Hai-Lun
Liu, Tong
Tang, Meng
Zhang, Qi
Zhang, Xi
Zhang, Kang-Ping
Li, Xiang-Rui
Li, Qin-Qin
Chen, Yong-Bing
Yu, Kai-Ying
Cong, Ming-Hua
Wang, Kun-Hua
Shi, Han-Ping
author_facet Ruan, Guo-Tian
Yang, Ming
Zhang, Xiao-Wei
Song, Meng-Meng
Hu, Chun-Lei
Ge, Yi-Zhong
Xie, Hai-Lun
Liu, Tong
Tang, Meng
Zhang, Qi
Zhang, Xi
Zhang, Kang-Ping
Li, Xiang-Rui
Li, Qin-Qin
Chen, Yong-Bing
Yu, Kai-Ying
Cong, Ming-Hua
Wang, Kun-Hua
Shi, Han-Ping
author_sort Ruan, Guo-Tian
collection PubMed
description BACKGROUND: Systemic inflammation and cachexia are associated with adverse clinical outcomes in elderly patients with cancer. The survival outcomes of elderly patients with cancer cachexia (EPCC) with high inflammation and a high risk of mortality are unknown. This study aimed to investigate the impact of high inflammation on the prognosis of EPCC patients with high mortality. PATIENTS AND METHODS: This multicenter cohort study included 746 EPCC (age >65 years) with a mean age of 72.00 ± 5.24 years, of whom 489 (65.5%) were male. The cut-off value for the inflammation index was obtained using the optimal survival curve. The different inflammatory indicators were assessed using the concordance index (C-index), decision curve analysis (DCA), and prognostic receiver operating characteristic (ROC). The high mortality risk group of EPCC was defined by the 2011 Fearon Cancer Diagnostic Consensus. EPCC were divided into the high-risk group, which satisfies three diagnostic criteria, and a low-risk group, which satisfies only one or two diagnostic criteria. RESULTS: The C-index, DCA, and prognostic ROC indicated the superiority of advanced lung cancer inflammation index (ALI) compared with other indicators, including neutrophil–lymphocyte ratio (NLR), prognostic nutritional index (PNI), systemic immune-inflammation index (SII), and platelet–lymphocyte ratio (PLR). Whether ALI was used as a continuous or a categorical variable, ALI had a better prognostic value in EPCC compared with other inflammatory indicators. In particular, patients with low ALI (<25.03) had a worse overall survival (OS) than patients with high ALI (≥25.03) (P < 0.001, HR [95% CI] = 2.092 [1.590–2.751]). The combination effect analysis showed that the risk of mortality of the patients in the low-ALI and high-risk groups was 3.095-fold higher than that of patients in the high-ALI and low-risk groups. CONCLUSION: The prognostic and discriminative value of the inflammatory indicator ALI was better than that of NLR, PNI, SII, and PLR in EPCC. The high-risk group of EPCC with a low ALI would increase the death risk of OS.
format Online
Article
Text
id pubmed-8558830
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85588302021-11-03 Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia – Results from a Multicenter Study Ruan, Guo-Tian Yang, Ming Zhang, Xiao-Wei Song, Meng-Meng Hu, Chun-Lei Ge, Yi-Zhong Xie, Hai-Lun Liu, Tong Tang, Meng Zhang, Qi Zhang, Xi Zhang, Kang-Ping Li, Xiang-Rui Li, Qin-Qin Chen, Yong-Bing Yu, Kai-Ying Cong, Ming-Hua Wang, Kun-Hua Shi, Han-Ping J Inflamm Res Original Research BACKGROUND: Systemic inflammation and cachexia are associated with adverse clinical outcomes in elderly patients with cancer. The survival outcomes of elderly patients with cancer cachexia (EPCC) with high inflammation and a high risk of mortality are unknown. This study aimed to investigate the impact of high inflammation on the prognosis of EPCC patients with high mortality. PATIENTS AND METHODS: This multicenter cohort study included 746 EPCC (age >65 years) with a mean age of 72.00 ± 5.24 years, of whom 489 (65.5%) were male. The cut-off value for the inflammation index was obtained using the optimal survival curve. The different inflammatory indicators were assessed using the concordance index (C-index), decision curve analysis (DCA), and prognostic receiver operating characteristic (ROC). The high mortality risk group of EPCC was defined by the 2011 Fearon Cancer Diagnostic Consensus. EPCC were divided into the high-risk group, which satisfies three diagnostic criteria, and a low-risk group, which satisfies only one or two diagnostic criteria. RESULTS: The C-index, DCA, and prognostic ROC indicated the superiority of advanced lung cancer inflammation index (ALI) compared with other indicators, including neutrophil–lymphocyte ratio (NLR), prognostic nutritional index (PNI), systemic immune-inflammation index (SII), and platelet–lymphocyte ratio (PLR). Whether ALI was used as a continuous or a categorical variable, ALI had a better prognostic value in EPCC compared with other inflammatory indicators. In particular, patients with low ALI (<25.03) had a worse overall survival (OS) than patients with high ALI (≥25.03) (P < 0.001, HR [95% CI] = 2.092 [1.590–2.751]). The combination effect analysis showed that the risk of mortality of the patients in the low-ALI and high-risk groups was 3.095-fold higher than that of patients in the high-ALI and low-risk groups. CONCLUSION: The prognostic and discriminative value of the inflammatory indicator ALI was better than that of NLR, PNI, SII, and PLR in EPCC. The high-risk group of EPCC with a low ALI would increase the death risk of OS. Dove 2021-10-27 /pmc/articles/PMC8558830/ /pubmed/34737602 http://dx.doi.org/10.2147/JIR.S332408 Text en © 2021 Ruan et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Ruan, Guo-Tian
Yang, Ming
Zhang, Xiao-Wei
Song, Meng-Meng
Hu, Chun-Lei
Ge, Yi-Zhong
Xie, Hai-Lun
Liu, Tong
Tang, Meng
Zhang, Qi
Zhang, Xi
Zhang, Kang-Ping
Li, Xiang-Rui
Li, Qin-Qin
Chen, Yong-Bing
Yu, Kai-Ying
Cong, Ming-Hua
Wang, Kun-Hua
Shi, Han-Ping
Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia – Results from a Multicenter Study
title Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia – Results from a Multicenter Study
title_full Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia – Results from a Multicenter Study
title_fullStr Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia – Results from a Multicenter Study
title_full_unstemmed Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia – Results from a Multicenter Study
title_short Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia – Results from a Multicenter Study
title_sort association of systemic inflammation and overall survival in elderly patients with cancer cachexia – results from a multicenter study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558830/
https://www.ncbi.nlm.nih.gov/pubmed/34737602
http://dx.doi.org/10.2147/JIR.S332408
work_keys_str_mv AT ruanguotian associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy
AT yangming associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy
AT zhangxiaowei associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy
AT songmengmeng associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy
AT huchunlei associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy
AT geyizhong associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy
AT xiehailun associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy
AT liutong associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy
AT tangmeng associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy
AT zhangqi associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy
AT zhangxi associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy
AT zhangkangping associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy
AT lixiangrui associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy
AT liqinqin associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy
AT chenyongbing associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy
AT yukaiying associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy
AT congminghua associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy
AT wangkunhua associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy
AT shihanping associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy